1 | Page: Immune Cells and Tissues Swailes Cells and Tissues of The

Total Page:16

File Type:pdf, Size:1020Kb

1 | Page: Immune Cells and Tissues Swailes Cells and Tissues of The Cells and Tissues of the Immune System N. Swailes, Ph.D. Department of Anatomy and Cell Biology Rm: B046A ML Tel: 5-7726 E-mail: [email protected] Required reading Mescher AL, Junqueira’s Basic Histology Text and Atlas, 12th Edition, Chapter 20: pp226-2480 Ross MH and Pawlina W, Histology: A text and Atlas, 6th Edition, Chapter 21: pp396-429 Learning objectives 1) Identify the major cells of the immune system and briefly outline their function 2) Describe the general structure of lymphoid tissue 3) Differentiate between primary and secondary immune organs 4) Identify the thymus and discuss the role of its cells in ‘educating’ immature T-cells 5) Identify a lymph node and outline how an immune response is triggered here 6) Identify the spleen and describe the role of red and white pulp in filtering the blood and reacting to blood borne antigens 7) Differentiate between MALT in the oral cavity (tonsils) 8) Know where to find and how to identify examples of BALT and GALT Major Take Home Points A. Lymphoid tissues are composed of different types of lymphocytes and supporting cells within a scaffold of Type III collagen/reticular fibers B. The major primary lymphoid organs are encapsulated organs where immature lymphocytes are born (bone marrow) and become immunocompetent (thymus) C. The major secondary lymphoid organs are encapsulated organs where immunocompetent lymphocytes differentiate into effector cells after exposure to antigen in the blood (spleen) or lymph (nodes) D. Mucosa Associated Lymphoid Tissues (MALT) are un-encapsulated areas of lymphoid tissue within the mucosa of organs that can be identified by their lining epithelium (tonsils, GALT: ileum and appendix, BALT) 1 | Page: Immune Cells and Tissues Swailes A1: Organization of the immune system 5a A. General organization 2 Organs of the immune system: 5b 1. Bone marrow (see MOHD1) - site of immune cell development 4 2. Thymus - located in superior mediastinum 5c - site of T-cell ‘education’ 3 3. Lymph nodes - filters lymph - a site where immune responses can be initiated 4. Spleen - filters the blood - largest lymphoid organ 1 - a site where immune responses can be initiated 5. MALT - Mucosa Associated Lymphoid Tissue located in the mucosa of a number of organs including - the tonsils - BALT (Bronchus Associated Lymphoid Tissue) - GALT (Gut Associated Lymphoid Tissue) - e.g.Peyer’s patch, appendix The organs of the immune system are composed of immune cells AND lymphoid tissue 2 | Page: Immune Cells and Tissues Swailes B. Immune cells There are two populations of immune cells: lymphocytes and supporting cells 1. Lymphocytes - are the main cellular constituent of lymphatic tissue - are classified as T-cells, B-cells and Natural Killer (NK) cells - all possess unique cell-surface markers called Cluster of Differentiation (CD) molecules a) T-cells - are born in the bone marrow but are educated in the thymus (hence the “T”) - all have CD2, CD3 and CD7 markers - all have a T-cell receptor (TCR) that recognizes antigens - are involved in cell mediated immune response (doesn’t involve antibodies) There are three types of T-cell: i. “Helper” CD4+ T-cells - are identifiable because they express a CD4 marker - help activity of other immune cells (e.g B-cell activiation)) ii. “Cytotoxic” CD8+ T-cells - are identifiable because they express a CD8 marker - recognize and destroy virus infected cells or tumor cells iii. “Gamma/Delta” γ/δ T-cells - have neither CD4 nor CD8 marker - colonize epithelia to form a first line of defense against mucosa breaching antigens BCR b) B-cells - are born and mature in the bone marrow - differentiate in lymphoid organs - have CD9, CD19, CD20 and CD24 markers - have a B-cell receptor (BCR) that recognizes antigens CD9, CD19 - are involved in the humoral immune response (involves antibodies) CD20, CD24 To activate a B-cell two signals are required: - B-cells must bind antigen at BCR - B-cells must bind an activated complementary T-helper cell Activated B-cells differentiate to form: i. Memory B-cells - respond rapidly when they next encounter the same antigen ii. Plasma cells - synthesize antibodies against the antigen 3 | Page: Immune Cells and Tissues Swailes CD16 CD56 CD94 c) Natural Killer/NK-cells Fc - are born and differentiate in the bone marrow - have CD16, CD56 and CD94 markers - have an Fc receptor that binds antibodies attached to tumor cells and virus infected cells - release perforin (a protein that punches holes in cell membranes) - release granzyme (enzyme that induces apoptosis) 2. Supporting cells a. Granulocytes i. Basophils - trigger allergic reactions and anaphylaxis - pro-inflammatory (release vasoactive agents; heparin) ii. Eosinophils - primarily anti-parasitic - migrate to areas of allergic reaction - degranulate to destroy antibody-antigen complex iii. Neutrophils - primarily antibacterial - phagocytose antibody-antigen complex - main component of pus b. Agranulocytes i. Monocytes - leave the circulation to form tissue macrophages (histiocytes) c. Antigen Presenting Cells (APCs) - phagocytose and breakdown antigen - display antigen fragments at the cell surface - interact with “Helper” T-cells and B-cells - Macrophages are APCs located throughout the body - Dendritic cells are APCs in the spleen and lymph nodes - Langerhans cells are APCs in the epidermis - Epithelioreticular cells are APCs in the thymus d. Other i. Reticular cells - fibroblast-like cells - synthesize the Type III collagen (reticular fibers) of lymphoid tissue. 4 | Page: Immune Cells and Tissues Swailes A2. Primary lymphoid organs Regions of the body where lymphocytes become immunocompetent (recognize self v non-self): 1. Bone Marrow (see MOHD1) - is the site of erythrocyte and leukocyte development from stem cells - was the subject of our histological investigations in MOHD1 - is the site of T-cell development, immature T-cells leave the marrow sinusoids and migrate to the thymus to mature - is the site of B-cell and NK-cell development and maturation, these cells are released into the blood stream for circulation 2. Thymus - develops in mediastinum from the third pharyngeal pouch - during development it is infiltrated by immature T-cells aka ‘thymocytes’ - forms a bilobed structure in the mediastinum that diminishes with age - is an encapsulated lymphoid organ a. General Structure - a connective tissue capsule gives off trabecula that surround thymic lobules - thymic lobules are organized into a medulla and cortex - the cortex is basophilic because it is packed with thymocytes and scattered epithelioreticular cells - the medulla is paler and contains Hassall’s corpuscles 5 | Page: Immune Cells and Tissues Swailes The cells of the thymic lobule play an important role in T-cell education (see below) 5. Negative selection 6. Single positive - in the medulla TCR receptors are - surviving T-cells lose a CD4 or exposed to huge array of self CD8 marker making them antigens on surface of Type V ‘cytotoxic’ or ‘helper’ epithelioreticular cells - those that bind are eliminated! 4. Corticomedullary junction - positive selected T-cells pass CORTEX CMJ MEDULLA through barrier created by failed! Type III and IV epithelio-reticular CD8 cells at the corticomedullary junction CD8 CD4 CD 4 3. Positive selection TCR - Type II epithelio - reticular cells express self MHC antigens. - if T-cells recognize CD8 these they pass CD4 - 80% fail and are killed! failed! failed! 2. CD4/CD8 T-cells - as they develop thymocytes express TCR and both CD4 and CD8 markers Hassall’s corpuscles (Type VI epithelioreticular cells) secrete cytokines that aid the education process 1. Thymocytes 7. Educated T-cells exit - immature T-cells in outer cortex - only about ~2% of thymocytes - naïve and do not express CD markers or TCRs re-enter the circulation as - Type I epithelioreticular cells form a blood-thymus functionally mature CD4+ or barrier ensuring T-cell exposure to antigen in the CD8+ T-cells thymus is a controlled event 6 | Page: Immune Cells and Tissues Swailes A3. Secondary lymphoid organs Regions of the body where immunocompetent lymphocytes differentiate into effector cells in an antigen dependent manner. 1. Lymph Nodes a. General Structure and function - bean shaped organs - located along the lymphatic vessels throughout body - encapsulated - filter the lymph - provide environment where antigen dependent differentiation of B-cells can take place i. Afferent lymphatics Lymph enters the node here ii. Capsule A dense irregular capsule iii. Subcapsular sinus Lymph drains into this space deep to the capsule iv. Trabeculae The capsule extends into the ix. Efferent lymphatics parenchyma to form trabeculae Lymph exits the node here v. Trabecular sinus The capsule extends into the parenchyma to form trabeculae vi. Cortex The outer cortex contains follicles. The paracortex contain HEVs vii. Medulla viii. Medullary sinuses The inner region of the lymphoid tissue. It is Lymph flows through these spaces as it organized into cords of lymphoid tissue proceeds through the medulla 7 | Page: Immune Cells and Tissues Swailes b. Flow of lymph The flow of lymph is important in ensuring the lymph node is a region where lymphocytes ( ) antigen ( ) and dendritic APCs ( ) can mix to promote B-cell differentiation i. Antigen-rich lymph enters at outer cortex paracortex afferent vessels and passes medulla into the subcapsular sinus vi. Lymph leaves via efferent lymphatics ii. Lymph percolate s through the lymphoid tissue in the medulla OR Travels direct ly through trabecular sinuses v. Lymph flows through the medullary sinuses iii. Macrophages & iv. Lymphocytes enter lymph nodes through high dendritic APCs trap and process endothelial venules (HEVs) in the paracortex antigen and present it to lymphocytes aiming to maximize B-cell, T-cell, antigen interaction c. Lymphoid nodules - The lymph node provides all the ingredients required to activate a B-cell! i. a constant flow of antigen filled lymph (filth!) ii. dendritic cells to sequester antigen and present it to lymphocytes iii. Helper T-cells ready to accept antigen and then bind their complementary B-cells iv.
Recommended publications
  • Characterization of Murine Macrophages from Bone Marrow
    Wang et al. BMC Immunology 2013, 14:6 http://www.biomedcentral.com/1471-2172/14/6 RESEARCH ARTICLE Open Access Characterization of murine macrophages from bone marrow, spleen and peritoneum Changqi Wang1*†, Xiao Yu1,2†, Qi Cao1, Ya Wang1, Guoping Zheng1, Thian Kui Tan1, Hong Zhao1,3, Ye Zhao1, Yiping Wang1 and David CH Harris1 Abstract Background: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. Results: We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β. Conclusions: Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Keywords: Macrophage, Bone marrow, Spleen, Peritoneum Background macrophage populations could be attributed to their het- Macrophages play an essential role in both innate and erogeneity [4].
    [Show full text]
  • Primary Splenic and Nodal Marginal Zone Lymphoma
    J. Clin. Exp. Hematopathol Vol. 45, No. 1, Aug 2005 Review Article Primary Splenic and Nodal Marginal Zone Lymphoma: Jacques Diebold, Agne`s Le Tourneau, Eva Comperat, Thierry Molina and Jose´ e Audouin Primary splenic and nodal marginal zone (MZ) lymphomas are rare small B cell lymphomas presenting with similar histopathologic features. The neoplastic cell population mostly consists of monocytoid B cells organized in a MZ pattern, associated with centrocytoid cells colonizing follicles. About 50% of cases have a monotypic plasma cell component. The different histopathologic patterns and differential diagnosis are discussed here. Both diseases share a similar immunophenotype, with the expression of B-cell associated antigens and restriction of immunoglobulin light chain. The only difference is the more frequent expression of IgD in splenic than in nodal lymphomas. The most recent findings in genetics and molecular biology are presented and discussed. The main clinical and biological symptoms are described and the similarity of some cases with Waldenstro¨ms macroglobulinemia is stressed. Both lymphomas present with the same type of bone marrow involvement with a high frequency of intravascular infiltrates, which can be associated with interstitial and nodular infiltrates. Transformation into diffuse large B cell lymphoma occurs in about 10 to 15% of the cases. The outcome in many splenic MZ lymphomas is characterized by a lengthy survival after splenectomy (9 to 13 years or longer), despite the absence of a consensus on the optimal treatment. Nodal MZ lymphoma has a more aggressive evolution and seems to only be curable at an early stage. Further studies are needed of both lymphomas to improve treatment and prognosis.
    [Show full text]
  • Cells, Tissues and Organs of the Immune System
    Immune Cells and Organs Bonnie Hylander, Ph.D. Aug 29, 2014 Dept of Immunology [email protected] Immune system Purpose/function? • First line of defense= epithelial integrity= skin, mucosal surfaces • Defense against pathogens – Inside cells= kill the infected cell (Viruses) – Systemic= kill- Bacteria, Fungi, Parasites • Two phases of response – Handle the acute infection, keep it from spreading – Prevent future infections We didn’t know…. • What triggers innate immunity- • What mediates communication between innate and adaptive immunity- Bruce A. Beutler Jules A. Hoffmann Ralph M. Steinman Jules A. Hoffmann Bruce A. Beutler Ralph M. Steinman 1996 (fruit flies) 1998 (mice) 1973 Discovered receptor proteins that can Discovered dendritic recognize bacteria and other microorganisms cells “the conductors of as they enter the body, and activate the first the immune system”. line of defense in the immune system, known DC’s activate T-cells as innate immunity. The Immune System “Although the lymphoid system consists of various separate tissues and organs, it functions as a single entity. This is mainly because its principal cellular constituents, lymphocytes, are intrinsically mobile and continuously recirculate in large number between the blood and the lymph by way of the secondary lymphoid tissues… where antigens and antigen-presenting cells are selectively localized.” -Masayuki, Nat Rev Immuno. May 2004 Not all who wander are lost….. Tolkien Lord of the Rings …..some are searching Overview of the Immune System Immune System • Cells – Innate response- several cell types – Adaptive (specific) response- lymphocytes • Organs – Primary where lymphocytes develop/mature – Secondary where mature lymphocytes and antigen presenting cells interact to initiate a specific immune response • Circulatory system- blood • Lymphatic system- lymph Cells= Leukocytes= white blood cells Plasma- with anticoagulant Granulocytes Serum- after coagulation 1.
    [Show full text]
  • Centers Differentiation Stages in Human Germinal Patterns Reflect
    Cutting Edge: Polycomb Gene Expression Patterns Reflect Distinct B Cell Differentiation Stages in Human Germinal Centers This information is current as of September 27, 2021. Frank M. Raaphorst, Folkert J. van Kemenade, Elly Fieret, Karien M. Hamer, David P. E. Satijn, Arie P. Otte and Chris J. L. M. Meijer J Immunol 2000; 164:1-4; ; doi: 10.4049/jimmunol.164.1.1 Downloaded from http://www.jimmunol.org/content/164/1/1 References This article cites 22 articles, 11 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/164/1/1.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. c Cutting Edge: Polycomb Gene Expression Patterns Reflect Distinct B Cell Differentiation Stages in Human Germinal Centers Frank M. Raaphorst,1* Folkert J. van Kemenade,* Elly Fieret,* Karien M.
    [Show full text]
  • Mantle Cell Lymphoma Stefano A
    Editorials and Perspectives ers in myeloproliferative diseases: relationships with JAK2 Pascutto C, et al. Relation between JAK2 (V617F) mutation V617 F status, clonality, and antiphospholipid antibodies. J status, granulocyte activation, and constitutive mobilization Thromb Haemost 2007;5:1679-85. of CD34+ cells into peripheral blood in myeloproliferative 17. Falanga A, Marchetti M, Vignoli A, Balducci D, Russo L, disorders. Blood 2006;107:3676-82. Guerini V, et al. V617F JAK-2 mutation in patients with 23. Alvarez-Larrán A, Arellano-Rodrigo E, Reverter JC, essential thrombocythemia: relation to platelet, granulo- Domingo A, Villamor N, Colomer D, et al. Increased cyte, and plasma hemostatic and inflammatory molecules. platelet, leukocyte, and coagulation activation in primary Exp Hematol 2007;35:702-11. myelofibrosis. Ann Hematol 2008;87:269-76. 18. Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, 24. Leibundgut EO, Horn MP, Brunold C, Pfanner-Meyer B, Colomer D, Villamor N, Bellosillo B, et al. Platelet turnover, Marti D, Hirsiger H, et al. Hematopoietic and endothelial coagulation factors, and soluble markers of platelet and progenitor cell trafficking in patients with myeloprolifera- endothelial activation in essential thrombocythemia: rela- tive diseases. Haematologica 2006;91:1465-72. tionship with thrombosis occurrence and JAK2 V617F allele 25. Sozer S, Fiel MI, Schiano T, Xu M, Mascarenhas J, Hoffman burden. Am J Hematol 2009;84:102-8. R. The presence of JAK2V617F mutation in the liver 19. Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk endothelial cells of patients with Budd-Chiari syndrome. HM, ten Cate H, Leyte A, et al. Elevated procoagulant Blood 2009;113:5246-9.
    [Show full text]
  • Leukaemic Phase of Mantle Zone (Intermediate) Lymphoma: Its Characterisation in 11 Cases
    J Clin Pathol: first published as 10.1136/jcp.42.9.962 on 1 September 1989. Downloaded from J Clin Pathol 1989;42:962-972 Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases M S POMBO DE OLIVEIRA,* E S JAFFE, D CATOVSKY* From the *Department ofHaematology and Cytogenetics, The Royal Marsden Hospital, London, and the Department ofPathology, National Cancer Institute, Bethesda, Maryland, United States ofAmerica SUMMARY Sixteen patients presented with B cell leukaemia (white cell count 26-269 x 109/1) which could not be classified as chronic lymphocytic (CLL), prolymphocytic leukaemia, or follicular lymphoma in leukaemic phase. Eleven patients (10 men, one woman) corresponded histologically to intermediate (INT) or mantle zone lymphoma, and five, with less well defined features, were designated small lymphocytic lymphoma with cleaved cells. The blood films showed a pleomorphic picture with lymphoid cells ofpredominantly medium size with nuclear irregularities and clefts. The membrane phenotype of the circulating cells showed strong immunoglobulin staining and reactivity with CD5 and FMC7 in all cases tested; CD1O was positive in six out of nine cases. The membrane phenotype of two of the five cases of small lymphocytic lymphoma was close to those of B-CLL and three resembled INT lymphoma. Bone marrow trephine biopsy specimens showed a diffuse pattern of infiltration in INT lymphoma. The median survival of these patients was less than two years, suggesting that a leukaemic presentation is associated with poor prognosis. By combining data from histology, membrane markers, and peripheral blood morphology, the leukaemic phase oftypical INTcopyright. lymphoma can be defined in most cases.
    [Show full text]
  • Lymphoid System IUSM – 2016
    Lab 14 – Lymphoid System IUSM – 2016 I. Introduction Lymphoid System II. Learning Objectives III. Keywords IV. Slides A. Thymus 1. General Structure 2. Cortex 3. Medulla B. Lymph Nodes 1. General Structures 2. Cortex 3. Paracortex 4. Medulla C. MALT 1. Tonsils 2. BALT 3. GALT a. Peyer’s patches b. Vermiform appendix D. Spleen 1. General Structure 2. White Pulp 3. Red Pulp V. Summary SEM of an activated macrophage. Lab 14 – Lymphoid System IUSM – 2016 I. Introduction Introduction II. Learning Objectives III. Keywords 1. The main function of the immune system is to protect the body against aberrancy: IV. Slides either foreign pathogens (e.g., bacteria, viruses, and parasites) or abnormal host cells (e.g., cancerous cells). A. Thymus 1. General Structure 2. The lymphoid system includes all cells, tissues, and organs in the body that contain 2. Cortex aggregates (accumulations) of lymphocytes (a category of leukocytes including B-cells, 3. Medulla T-cells, and natural-killer cells); while the functions of the different types of B. Lymph Nodes lymphocytes vary greatly, they generally all appear morphologically similar so cannot be 1. General Structures routinely distinguished in light microscopy. 2. Cortex 3. Lymphocytes can be found distributed throughout the lymphoid system as: (1) single 3. Paracortex cells, (2) isolated aggregates of cells, (3) distinct non-encapsulated lymphoid nodules in 4. Medulla loose CT associated with epithelium, or (4) encapsulated individual lymphoid organs. C. MALT 1. Tonsils 4. Primary lymphoid organs are sites where lymphocytes are formed and mature; they 2. BALT include the bone marrow (B-cells) and thymus (T-cells); secondary lymphoid organs are sites of lymphocyte monitoring and activation; they include lymph nodes, MALT, and 3.
    [Show full text]
  • Clinical Chemistry Trainee Council Pearls of Laboratory Medicine
    Clinical Chemistry Trainee Council Pearls of Laboratory Medicine www.traineecouncil.org TITLE: Lymph Node Structure and Function PRESENTER: Teresa S. Kraus, MD Slide 1: Hello, my name is Teresa Kraus, and I am an assistant professor and medical director of the clinical hematology laboratory at the University of Oklahoma Health Sciences Center. Welcome to this Pearl of Laboratory Medicine on “Lymph Node Structure and Function.” Slide 2: Primary lymphoid tissues are sites of foreign antigen-independent lymphoid differentiation. B cell precursors originate, and undergo the early stages of differentiation, in the bone marrow, and enter the circulation as mature naïve B cells. T cell progenitors originate in the bone marrow and migrate to the thymus where they undergo selection and mature into naïve T cells, which express either CD4 or CD8. The secondary lymphoid tissues include the lymph nodes, spleen, and mucosa-associated lymphoid tissue (MALT). At these sites, naïve B and T cells encounter foreign antigens and undergo antigen- dependent maturation. Slide 3: Lymphatic vessels are present throughout most of the body, and drain excess interstitial fluid from tissues, eventually returning the fluid to the circulation via the subclavian veins. Lymph nodes are present at multiple points along the lymphatic network, and are particularly frequent along major vessels; in the neck, axillae, and groin; the mediastinum, and mesentery. Slide 4: Lymph nodes are small, bean-shaped structures, usually measuring between 0.2 and 2 cm, and are surrounded by a fibrous capsule. Fibrous trabeculae projecting from the capsule lend structural support to the lymph node. The lymph node can be separated into three cellular compartments: the cortex, paracortex, and medulla.
    [Show full text]
  • Landscape of T Follicular Helper Cell Dynamics in Human Germinal Centers
    Landscape of T Follicular Helper Cell Dynamics in Human Germinal Centers Emmanuel Donnadieu, Kerstin Bianca Reisinger, Sonja Scharf, Yvonne Michel, Julia Bein, Susanne Hansen, This information is current as Andreas G. Loth, Nadine Flinner, Sylvia Hartmann and of September 28, 2021. Martin-Leo Hansmann J Immunol published online 22 July 2020 http://www.jimmunol.org/content/early/2020/07/21/jimmun ol.1901475 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2020/07/21/jimmunol.190147 Material 5.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2020 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 22, 2020, doi:10.4049/jimmunol.1901475 The Journal of Immunology Landscape of T Follicular Helper Cell Dynamics in Human Germinal Centers Emmanuel Donnadieu,*,1 Kerstin Bianca Reisinger,†,1 Sonja Scharf,† Yvonne Michel,† Julia Bein,†,‡ Susanne Hansen,† Andreas G. Loth,x Nadine Flinner,{ Sylvia Hartmann,†,‡ and Martin-Leo Hansmann†,‡,{ T follicular helper (Tfh) cells play a very important role in mounting a humoral response.
    [Show full text]
  • PRIMARY SPLENIC LYMPHOMA: DOES IT EXIST ? Paolo G
    review Haematologica 1994; 79:286-293 PRIMARY SPLENIC LYMPHOMA: DOES IT EXIST ? Paolo G. Gobbi, Giovanni E. Grignani, Ugo Pozzetti, Daniele Bertoloni, Carla Pieresca, Giovanni Montagna, Edoardo Ascari Clinica Medica II, Dipartimento di Medicina Interna, Università degli Studi di Pavia, IRCCS Policlinico S. Matteo, Pavia, Italy ABSTRACT The number of primary splenic lymphomas being reported is increasing despite the rarity of this malignancy, but what really constitutes a lymphoma arising primarily in the spleen is still a matter of discussion. The authors choose the “restrictive” definition of a lymphoma involving the spleen and the splenic hilar lymph nodes only. In this way, the risk of epidemiologic or clinical overestimation is avoided. The clinical features of this condition are characterized by non specific symptoms and signs, while the prevailing histology is that of a low-grade or intermediate-type lymphoma. Disease spreading outside of the spleen and its hilar lymph nodes is the single most important factor asso- ciated with an unfavorable prognosis. From this usual clinical picture, two distinct nosologic entities can be outlined on the basis of histologic and immunologic peculiarities: splenic lymphoma with circulating villous lymphocytes and marginal-zone splenic lymphoma. The former arises from follicular center cells and is char- acterized by hypersplenism, variable percentages of circulating villous lymphocytes and, fre- quently, a monoclonal gammopathy. The latter originates from a peculiar splenic B-cell structure separated by the mantle zone. The proliferating cells are medium-sized KiB3-positive lympho- cytes with round or cleaved nuclei and pale cytoplasm, which surround follicular centers and infiltrate the mantle zone.
    [Show full text]
  • Castleman's Disease—A Two Compartment Model of HHV8 Infection
    REVIEWS Castleman’s disease—a two compartment model of HHV8 infection Klaus-Martin Schulte and Nadia Talat Abstract | Castleman’s disease is a primary infectious disease of the lymph node that causes local symptoms or a systemic inflammatory syndrome. Histopathology reveals a destroyed lymph node architecture that can range from hyaline‑vascular disease to plasma‑cell disease. Viral interleukin 6 (vIL‑6) produced during the replication of human herpesvirus type 8 (HHV8) is the key driver of systemic inflammation and cellular proliferation. Stage progression of Castleman’s disease results from switches between viral latency and lytic replication, and lymphatic and hematogenous spread. Multicentric plasma‑cell disease in HIV‑1 patients is associated with HHV8 infection. Polyclonal plasmablast proliferation escapes control in the germinal center with eventual malignant transformation into non‑Hodgkin lymphoma. Surgery produces excellent results in unicentric disease, while multicentric disease responds to anti‑CD20 therapy or IL‑6 and chemotherapy. Lymphovascular endothelium and naive B cells are infectious reservoir‑opening options for antiangiogenic and anti‑CD19 strategies to enhance outcomes in patients with systemic disease. Schulte, K.‑M. & Talat, N. Nat. Rev. Clin. Oncol. 7, 533–543 (2010); published online 6 July 2010; doi:10.1038/nrclinonc.2010.103 Introduction Castleman’s disease was first described in a case report by hyaline-vascular type and the plasma-cell type. Frequent Castleman and Towne1 in 1954, which was followed by a transitions between types have led to the identification series in 1956.2 It is a unicentric or multicentric disease of of the mixed type that is reported in 15% of cases.3 The the lymph node with or without polyclonal proliferation other major pathological classification scheme is that of B cells.
    [Show full text]
  • The Spleen ABOLARIN A.T BUTH, OGBOMOSO Outline
    The Spleen ABOLARIN A.T BUTH, OGBOMOSO Outline Structure and physiology Functions Diseases associated with the spleen The major functions of the spleen are (i) filtration and ‘quality control’ of red cells within the circulation (ii) capture and destruction of blood-borne pathogens (iii) generation of adaptive immune responses. In order to achieve these aims the Spleen has evolved a unique anatomical structure that is based on the filtering of blood through two main systems. These consist of a white pulp, which is concerned mainly with immunological function, and a red pulp, which regulates the selection of red cells for re-entry into the circulation. Structure of the spleen The normal spleen weighsabout 150–250 g, but there is considerable variation between normal individuals and at various ages in the same individual. At puberty it weighs about 200–300 g but after the age of 65 years this decreases to 100–150 g or less. In the adult its length is 8–13cm, width 4.5–7.0 cm, surface area 45– 80 cm2 and volume less than 275 cm3. A spleen greater than 14 cm long is usually palpable. Blood flow It is enclosed by a connective tissue framework that extends inwards to form a fibrous network. Blood enters at the pelvis and the majority of vessels open into these open networks(the red pulp) before re-entering the closed venous system. There is no afferent lymphatic to the spleen and the efferent lymphatic system leaves along the route of the splenic vein. The spleen contains a large amount of lymphatic tissue that is mostly concentrated in concentric rings around the arterioles (white pulp).
    [Show full text]